Used as a key intermediate in the synthesis of fluoroquinolone antibiotics, particularly in the production of advanced pharmaceutical agents with enhanced antimicrobial activity. Its structure allows for selective functionalization, making it valuable in developing drugs targeting DNA gyrase and topoisomerase IV in pathogenic bacteria. Also employed in research settings to design novel bioactive molecules due to the combined presence of fluorine and hydroxyl groups, which improve metabolic stability and binding affinity.